GlassScriptPhysician profile
Priya Davar
NPI 1831585603
$3,437.46
in general payments reported to CMS, 2019-2025
33 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $820 · 2023: $355 · 2024: $778 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $737.22 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $255.05 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $236.06 | 2024-2025 | Repatha, Evenity, Otezla |
| Pfizer INC. | $231.21 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $200.00 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $199.71 | 2021-2025 | Lagevrio, Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $153.40 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $137.84 | 2024-2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $122.74 | 2022-2025 | Yeztugo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.98 | 2022-2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.72 | 2022-2023 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $95.48 | 2023-2024 | Rexulti |
| Inspire Medical Systems, INC. | $89.16 | 2023-2025 | Inspire |
| Abbott Laboratories | $86.14 | 2024-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $79.13 | 2025 | Tymlos |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $77.96 | 2025 | Zoryve |
| Amarin Pharma, INC. | $71.70 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $48.37 | 2022-2025 | Quviviq, Quviviq |
| Abbvie INC. | $44.06 | 2022-2023 | Vraylar |
| Corium, LLC | $41.59 | 2022-2024 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $40.72 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.10 | 2024 | Trintellix |
| Biosense Webster, INC. | $33.19 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.79 | 2022 | |
| Phathom Pharmaceuticals, INC. | $27.10 | 2024 | Voquezna |
| Acclarent, INC | $24.04 | 2022 | |
| Medtronic, INC. | $21.89 | 2022 | |
| Viiv Healthcare Company | $21.33 | 2025 | Apretude |
| Edwards Lifesciences Corporation | $16.74 | 2022 | |
| Esperion Therapeutics, INC. | $16.61 | 2025 | Nexletol |
| Seqirus USA INC | $16.61 | 2022 | |
| Currax Pharmaceuticals LLC | $15.85 | 2022 | |
| Mayne Pharma Commercial LLC | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Davar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.